| 2025年度 |
LOGIK |
LOGIK2401 |
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study) |
Cancer Treat Res Commun |
DOI ↗
|
久留米大学
石井 秀宣 |
| 2025年度 |
LOGIK |
TOP-ILD |
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicenter, single-arm phase 2 study (TOP-ILD) |
ERJ Open Res |
DOI ↗
|
九州大学
坪内 和哉 |
| 2025年度 |
LOGIK |
LOGIK2102 |
Atezolizumab with carboplatin plus nab-paclitaxel
combination therapy for TTF-1 negative advanced nonsquamous non–small cell lung cancer: a multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102) |
Eur J Cancer |
DOI ↗
|
九州大学
白石 祥理 |
| 2025年度 |
その他 |
肺の生活習慣病コホート研究 |
Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias |
BMC Pulm Med |
DOI ↗
|
九州大学
萩原 拓貴 |
| 2025年度 |
W-JHS |
W-JHS AA01 |
Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study |
Br J Haematol |
DOI ↗
|
国立国際医療センター
石山 謙 |
| 2025年度 |
その他 |
肺の生活習慣病 コホート研究 |
Association between single nucleotide polymorphisms and disease susceptibility, survival, and acute exacerbation in idiopathic pulmonary fibrosis |
Respirology |
DOI ↗
|
九州大学
坪内 和哉 |
| 2025年度 |
LOGIK |
LOGIK2001 |
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED) |
ESMO Open 2025; 10: 105325. |
DOI ↗
|
九州大学
白石 祥理 |
| 2025年度 |
LOGIK |
LOGIK0902/ OLCSG0905 |
Retreatment With EGFR-Tyrosine Kinase
Inhibitor After Disease Progression Following
Gefitinib Induction and Chemoradiotherapy in
EGFR-Mutant Stage III Non-small Lung Cancer:
An Efficacy and Safety Analysis of the
LOGIK0902/OLCSG0905 Study |
Cureus 17(6): e86575. |
DOI ↗
|
熊本中央病院
佐伯 祥 |
| 2025年度 |
その他 |
J-FOCAL |
Multicenter cohort study of the effect of Crinone® progesterone vaginal gel alone to prepare the endometrium for frozen–thawed blastocyst transfer in a hormone replacement cycle |
J Obstet Gynaecol Res
2025; 51, e16325 |
DOI ↗
|
東邦大学医療センター佐倉病院
高島 明子 |
| 2025年度 |
その他 |
肺の生活習慣病コホート研究 |
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study |
Sci Rep |
DOI ↗
|
九州大学
緒方 大聡 |
| 2025年度 |
LOGIK |
LOGIK2003 |
Turtle study: A phase II study of durvalumab plus carboplatin and etoposide in elderly patients with extensive-stage small-cell lung cancer (LOGIK 2003) |
JTO Clin Res Rep |
DOI ↗
|
久留米大学
石井 秀宣 |
| 2025年度 |
LOGIK |
LOGIK2002 |
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal
function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002) |
Lung Cancer 203 (2025) 108543 |
DOI ↗
|
九州大学
白石 祥理 |
| 2024年度 |
LOGIK |
LOGIK0902/ OLCSG0905 |
Five-Year Outcomes with Gefitinib Induction and Chemoradiotherapy in EGFR-Mutant
Stage III Non-Small-Cell Lung Cancer: LOGIK0902/OLCSG0905 Phase II Study |
Int J Clin Oncol |
DOI ↗
|
岡山大学
堀田 勝幸 |
| 2024年度 |
その他 |
BIO-NEXT |
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study) |
Front Immunol |
DOI ↗
|
九州がんセンター
佐藤 晋彰 |
| 2024年度 |
その他 |
肺の生活習慣病コホート研究 |
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry |
BMC Pulm Med |
DOI ↗
|
九州大学
髙野 智嗣 |